The survival of bone marrow- or peripheral blood-derived blasts from AML patients was assessed in short-term cultures upon small interfering RNA (siRNA)-mediated PDP1 knockdown and compared with non-targeting (scrambled) siRNA controls. Here, PDP1 is linked to acute myeloid leukemia.